Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Martin Smith
No social account linked
Launched
12mo ago
2025-11-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Sep 2026 · Oct 2026 pending
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Break out of 2D - Create immersive AR experiences in moments

    Nov 6, 2025 · 12mo agoLaunch page

Store data

App Store
App Store App Store
Update date not synced
Rating
Rating not syncedRating count not synced
New ratings last mo
—
Price & IAP
FreeIAP data not synced
Current version
—Store metadata

Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search36%
  • Referrals9%
  • Social6%
  • Other10%

Countries

  • India92%
  • Pakistan8%

Search

Domain authority —Domain registered 2020-04-07

KeywordMonthly volume
apple vision pro170.5K
glb34.8K
glb file9,300
trace studio220
3 dof in 6dof30

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2025-11-06

Key pages

Weekly snapshots
www.trace3d.app/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Trace get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Trace and what platforms does it support?
Trace is catalogued under 3D & AR/VR: Extend Reality. Supported platforms: Mobile App.

Related products in this category

Design / 3D & AR/VR

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.